1.
Prevalence of chronic kidney disease in China: a cross-sectional survey
by Zhang, Luxia, MD
The Lancet (British edition), 2012, Vol.379 (9818), p.815-822
2.
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study...
by Roth, David, Dr
The Lancet (British edition), 2015, Vol.386 (10003), p.1537-1545
3.
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S
Nature medicine, 2019, Vol.25 (11), p.1753-1760
4.
The double challenge of resistant hypertension and chronic kidney disease
by Rossignol, Patrick, Prof
The Lancet (British edition), 2015, Vol.386 (10003), p.1588-1598
5.
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study
by Tonelli, Marcello, Dr
The Lancet (British edition), 2012, Vol.380 (9844), p.807-814
6.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
by Gansevoort, Ron T, Dr
The Lancet (British edition), 2013, Vol.382 (9889), p.339-352
7.
Large Artery Stiffening and Remodeling Are Independently Associated With All-Cause Mortality and Cardiovascular Events in Chronic Kidney Disease
by Karras, Alexandre
Hypertension (Dallas, Tex. 1979), 2012, Vol.60 (6), p.1451-1457
8.
Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
by Ravizza, Stefan
Nature medicine, 2019, Vol.25 (1), p.57-59
9.
Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
by Soliman, Elsayed Z., MD, MSc, MS
The American heart journal, 2010, Vol.159 (6), p.1102-1107
10.
Anemia: progress in molecular mechanisms and therapies
by Sankaran, Vijay G
Nature medicine, 2015, Vol.21 (3), p.221-230
11.
Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients
by Kim, Sang Soo
Journal of diabetes and its complications, 2016, Vol.30 (5), p.887-892
12.
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
by Jamal, Sophie A, Dr
The Lancet (British edition), 2013, Vol.382 (9900), p.1268-1277
13.
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study
by Thomas, George
Hypertension (Dallas, Tex. 1979), 2016, Vol.67 (2), p.387-396
14.
Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans
by Molnar, Miklos Z
Thorax, 2015, Vol.70 (9), p.888-895
15.
Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus
by Liu, Jian-Jun
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (10), p.3683-3691
16.
Renal pathological implications in type 2 diabetes mellitus patients with renal involvement
by Li, Li
Journal of diabetes and its complications, 2016, Vol.31 (1), p.114-121
17.
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes
by Viazzi, Francesca
Journal of diabetes and its complications, 2016, Vol.31 (2), p.419-426
18.
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
by Swerdlow, AJ
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (5), p.1661-1672
19.
Hypertriglyceridemia in the Genomic Era: A New Paradigm
by Lewis, Gary F
Endocrine reviews, 2015, Vol.36 (1), p.131-147
20.
Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Prof...
by Parati, Gianfranco
Hypertension (Dallas, Tex. 1979), 2016, Vol.67 (6), p.1102-1110
